Distribution of angiographic measures of restenosis after drug-eluting stent implantation

Heart

Volumn 95, Issue 19, 2009, Pages 1572-1578

  Byrne, Robert A ^a   Eberle, S ^b   Kastrati, A ^a   Dibra, A ^a   Ndrepepa, G ^a   Iijima, R ^a   Mehilli, J ^a   Schomig A ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b GLAXOSMITHKLINE   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PACLITAXEL; RAPAMYCIN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CATHETERIZATION; CINEANGIOGRAPHY; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RESTENOSIS;

AGED; BLOOD VESSEL PROSTHESIS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PACLITAXEL; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; SIROLIMUS; TREATMENT OUTCOME; TUBULIN MODULATORS;

EID: 70349451933     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.161398     Document Type: Article

References (25)

1. Kuntz RE, Safian RD, Levine MJ, et al. Novel approach to the analysis of restenosis after the use of three new coronary devices. J Am Coll Cardiol 1992;19:1493-1499
2. Rensing BJ, Hermans WR, Deckers JW, et al. Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: a quantitative angiographic study in 1,445 successfully dilated lesions. J Am Coll Cardiol 1992;19:939-945
3. Kuntz RE, Baim DS. Defining coronary restenosis. Newer clinical and angiographic paradigms. Circulation 1993;88:1310-1323
4. Lehmann KG, Melkert R, Serruys PW. Contributions of frequency distribution analysis to the understanding of coronary restenosis. A reappraisal of the gaussian curve. Circulation 1996;93:1123-1132
5. Schomig A, Kastrati A, Elezi S, et al. Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement. Circulation 1997;96:3880-3887 (Pubitemid 27506045)
6. Strauss BH, Serruys PW, de Scheerder IK, et al. Relative risk analysis of angiographic predictors of restenosis within the coronary Wallstent. Circulation 1991;84:1636-1643
7. Kastrati A, Schomig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997;30:1428-1436 (Pubitemid 27486458)
8. Hermans WR, Rensing BJ, Foley DP, et al. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. J Cardiovasc Pharmacol 1993;22(Suppl 4):S45-57.
9. Kastrati A, Dibra A, Mehilli J, et al. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 2006;113:2293-2300 (Pubitemid 43947975)
10. Iijima R, Ndrepepa G, Mehilli J, et al. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. Am Heart J 2007;154:688-693 (Pubitemid 47440084)
11. Roy P, Okabe T, Pinto Slottow TL, et al. Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents. Am J Cardiol 2007;100:965-969 (Pubitemid 47368105)
12. Kereiakes DJ, Kuntz RE, Mauri L, et al. Surrogates, substudies, and real clinical end points in trials of drug-eluting stents. J Am Coll Cardiol 2005;45:1206-1212 (Pubitemid 40523138)
13. Redner R, Walker H. Mixture density, maximum likelihood and the EM-algorithm. Soc Ind Appl Mathemat 1984;26:195-238. (Pubitemid 17491604)
14. Henderson AR. The bootstrap: a technique for data-driven statistics. Using computer-intensive analyses to explore experimental data. Clin Chim Acta 2005;359:1-26.
15. Agostoni P, Cosgrave J, Biondi-Zoccai GG, et al. Angiographic analysis of pattern of late luminal loss in sirolimus- and paclitaxel-eluting stents. Am J Cardiol 2007;99:593-598 (Pubitemid 46273293)
16. Cosgrave J, Melzi G, Corbett S, et al. Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice. J Am Coll Cardiol 2007;49:2320-2328 (Pubitemid 46900991)
17. Byrne RA, Sarafoff N, Schömig A, et al. Drug-eluting stents in percutaneous coronary interventions: a benefit: risk assessment. Drug Safety (in press).
18. Mauri L, Orav EJ, Candia SC, et al. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials. Circulation 2005;112:2833-2839 (Pubitemid 41641678)
19. Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 2005;111:3435-3442 (Pubitemid 40923397)
20. Mauri L, Orav EJ, O'Malley AJ, et al. Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. Circulation 2005;111:321-327 (Pubitemid 40165339)
21. Pocock SJ, Lansky AJ, Mehran R, et al. Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol 2008;51:23-32.
22. Morice MC, Colombo A, Meier B, et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 2006;295:895-904. (Pubitemid 43295824)
23. Gibson CM, Kuntz RE, Nobuyoshi M, et al. Lesion-to-lesion independence of restenosis after treatment by conventional angioplasty, stenting, or directional atherectomy. Validation of lesion-based restenosis analysis. Circulation 1993;87:1123-1129
24. Kastrati A, Schomig A, Elezi S, et al. Interlesion dependence of the risk for restenosis in patients with coronary stent placement in in multiple lesions. Circulation 1998;97:2396-2401 (Pubitemid 28278182)
25. Byrne RA, Iijima R, Mehilli J, et al. Durability of anti-restenotic efficacy in drug-eluting stents with and without permanent polymer. J Am Coll Cardiol Interv 2009;2:291-299